Geneviève Choquet-Kastylevsky

Title: Geneviève Choquet-Kastylevsky: Innovator in Cancer Diagnostics

Introduction

Geneviève Choquet-Kastylevsky is a notable inventor based in Francheville, France. He has made significant contributions to the field of cancer diagnostics, particularly through his innovative methods for detecting tumor markers. With a total of 3 patents, his work has the potential to impact early diagnosis and therapeutic follow-up in oncology.

Latest Patents

One of his latest patents is the Prodefensin-A6 assay method for the in vitro diagnosis of colorectal cancer. This invention relates to a method for diagnosing colorectal cancer by determining the presence of the Prodefensin-A6 tumor marker in a biological sample from a patient suspected of having the disease. This method can be utilized for early diagnosis, screening, therapeutic follow-up, prognosis, and relapse diagnosis related to colorectal cancer. Another significant patent is the method for ProNGF assay for in vitro diagnosis of various cancers, including breast, thyroid, or lung cancer. This invention also includes a ProNGF inhibitor for preparing a drug that is particularly useful for blocking remote dissemination and cell invasion in cancer patients.

Career Highlights

Geneviève has worked with prominent organizations such as bioMérieux, Inc. and Université des Sciences et Technologies de Lille. His experience in these institutions has allowed him to develop and refine his innovative diagnostic methods.

Collaborations

He has collaborated with notable coworkers, including Yasemin Ataman-Önal and Corinne Beaulieu, contributing to advancements in cancer research and diagnostics.

Conclusion

Geneviève Choquet-Kastylevsky's work in cancer diagnostics exemplifies the importance of innovation in medical science. His patents and collaborations highlight his commitment to improving patient outcomes through advanced diagnostic methods.